Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Sell
139,065
-74,636
-35% -$233K ﹤0.01% 1061
2026
Q1
$624K Buy
+213,701
New +$611K 0.01% 721
2025
Q3
– Sell
-936,411
Closed -$2.25M – 996
2025
Q2
$2.25M Buy
+936,411
New +$2.28M 0.04% 273
2018
Q3
– Sell
-64,527
Closed -$299K – 559
2018
Q2
$299K Buy
+64,527
New +$379K 0.03% 397
2017
Q1
– Sell
-3,370,360
Closed -$16.5M – 624
2016
Q4
$16.5M Buy
+3,370,360
New +$18.2M 0.52% 44
2015
Q4
– Sell
-63,807
Closed -$312K – 424
2015
Q3
$312K Buy
+63,807
New +$346K 0.1% 208

Other funds holding ABEV

Quadrature Capital's ABEV Position: Q2 2026 in Review

Quadrature Capital reduced its Ambev (ABEV) stake by 35% in Q2 2026, selling an estimated $233K and leaving 139,065 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #1061.

Quadrature Capital first reported a position in ABEV in Q3 2015 and has held it in 6 quarters since. The position peaked at $16.5M in Q4 2016. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Quadrature Capital held 139,065 shares of Ambev worth $437K as of Q2 2026.
  • Quadrature Capital sold 74,636 Ambev shares in Q2 2026, an estimated $233K.
  • Ambev made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1061 holding.
  • Quadrature Capital first reported a position in Ambev in Q3 2015 and has held it in 6 quarters since.
  • Quadrature Capital's Ambev position peaked at $16.5M in Q4 2016.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.